in this issue
Regions :: North Asia :: Taiwan
ScinoPharm Invests in High Potency Facility
12:53 PM MDT | July 3, 2012 | Deepti Ramesh
Active pharmaceutical ingredient (API) manufacturer ScinoPharm Taiwan (Shanhua, Taiwan) says it will invest NT$1.13 billion ($38 million) to build a high potency cytotoxic injectable plant for oncological injectable products at the company's site at the Tainan Science Park in Taiwan. ScinoPharm, which is a global leader in supplying oncological APIs for injectable products, currently has the highest number of oncological APIs within the generic industry, the company says. “By expanding into the field of oncological injectable formulation, ScinoPharm will be...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee